Choreo LLC decreased its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 23.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,394 shares of the financial services provider's stock after selling 3,818 shares during the quarter. Choreo LLC's holdings in Aflac were worth $1,277,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of AFL. Darwin Wealth Management LLC purchased a new stake in shares of Aflac in the third quarter valued at $34,000. Raelipskie Partnership purchased a new stake in shares of Aflac in the third quarter valued at $38,000. Covestor Ltd raised its stake in shares of Aflac by 41.8% in the third quarter. Covestor Ltd now owns 363 shares of the financial services provider's stock valued at $41,000 after acquiring an additional 107 shares during the period. Kennebec Savings Bank purchased a new stake in shares of Aflac in the third quarter valued at $45,000. Finally, Catalyst Capital Advisors LLC purchased a new stake in shares of Aflac in the third quarter valued at $51,000. Hedge funds and other institutional investors own 67.44% of the company's stock.
Insider Activity
In other news, EVP Audrey B. Tillman sold 24,744 shares of the firm's stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now directly owns 222,618 shares in the company, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.90% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on AFL shares. StockNews.com downgraded shares of Aflac from a "hold" rating to a "sell" rating in a research note on Thursday, February 6th. JPMorgan Chase & Co. increased their target price on shares of Aflac from $90.00 to $94.00 and gave the company a "neutral" rating in a research note on Tuesday, January 7th. Evercore ISI cut their price target on shares of Aflac from $104.00 to $102.00 and set an "underperform" rating on the stock in a report on Wednesday, December 4th. Wells Fargo & Company upped their price target on shares of Aflac from $103.00 to $104.00 and gave the stock an "equal weight" rating in a report on Tuesday, January 14th. Finally, Truist Financial upped their price target on shares of Aflac from $100.00 to $105.00 and gave the stock a "hold" rating in a report on Friday, November 1st. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $103.00.
Get Our Latest Research Report on Aflac
Aflac Stock Down 0.0 %
Aflac stock traded down $0.01 during midday trading on Wednesday, hitting $102.98. 1,811,961 shares of the company's stock were exchanged, compared to its average volume of 1,827,316. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. Aflac Incorporated has a 12 month low of $77.01 and a 12 month high of $115.50. The firm has a 50-day moving average of $104.41 and a two-hundred day moving average of $107.07. The company has a market cap of $57.21 billion, a PE ratio of 10.73, a P/E/G ratio of 2.10 and a beta of 0.99.
Aflac (NYSE:AFL - Get Free Report) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, analysts expect that Aflac Incorporated will post 6.95 earnings per share for the current fiscal year.
Aflac Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Wednesday, February 19th will be issued a $0.58 dividend. This is a boost from Aflac's previous quarterly dividend of $0.50. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date is Wednesday, February 19th. Aflac's dividend payout ratio (DPR) is currently 20.83%.
Aflac Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles

Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.